Nick Pace Named EVP -- Operations, Compliance, and Regulatory PR Newswire RICHMOND, Va., March 25, 2013 RICHMOND, Va., March 25, 2013 /PRNewswire/ --Health Diagnostic Laboratory, Inc. (HDL, Inc.) has named Nicholas J. Pace, former executive vice president with Amerigroup as Executive Vice President of Operations, Compliance and Regulatory at the growing health management and advanced testing company. "The healthcare and biotechnology industries are well-known for their operational, compliance, and regulatory complexities, and Nick is similarly well-known for his capabilities in helping companies operate effectively and excel within this environment," said Tonya Mallory, CEO, President, and Co-founder of HDL, Inc. "We look forward to having Nick on our growing team of healthcare and business leaders." Most recently, Pace served as executive vice president, general counsel and secretary of Amerigroup, a multi-state publicly traded managed care organization focused on publicly sponsored health programs. Prior to joining Amerigroup in 2006, Pace served as assistant general counsel of CarMax, Inc., the publicly traded auto retailer based in Goochland County, and earlier in his career practiced corporate law at a firm in Silicon Valley. Prior to practicing law, the cum laude graduate of the University of Richmond T.C. Williams School of Law served as a consultant in Ernst & Young's tax group. Pace also holds a master's degree in business administration from the E. Claiborne Robins School of Business at U of R. "I sincerely appreciate the opportunity to join such a fast-growing company that is having a remarkably positive impact on health outcomes for thousands of Americans. I look forward to helping the company continue its successful growth and expand its offerings that allow for the delivery of more efficient and cost-effective care," Pace said. About Health Diagnostic Laboratory, Inc. Health Diagnostic Laboratory, Inc. (HDL, Inc.), a CAP accredited leader in health management, offers a comprehensive test menu of risk factors and biomarkers for cardiovascular disease, diabetes, and related diseases. Our systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. As an added value, patients receive a personalized overview of their risk factors along with intensive counseling from expert Clinical Health Consultants at no additional cost, improving compliance and enhancing satisfaction. For more information about HDL, Inc., visit www.hdlabinc.com. SOURCE HDL, Inc. Website: http://www.hdlabinc.com Contact: Paul Spicer, 804-503-9231, email@example.com
Nick Pace Named EVP -- Operations, Compliance, and Regulatory
Press spacebar to pause and continue. Press esc to stop.